Skip to content

Insider · CIK 0001643049

Dekker Martin

Reports to the SEC for 1 company · HAMPTON, NJ

Transactions

18

Companies

1

Filings

15

CIK

0001643049

Forms 4 and 5

Insider transactions

18 trades
DateCompanyValue
2023-06-07Bellerophon Therapeutics, Inc.Stock Options (Right to Buy)A Award—
2023-02-10Bellerophon Therapeutics, Inc.Stock Options (right to buy)A Award+$76K
2022-12-09Bellerophon Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion—
2022-12-09Bellerophon Therapeutics, Inc.F Tax Payment−$7,286.403
2022-12-09Bellerophon Therapeutics, Inc.M Exercise/Conversion—
2022-01-26Bellerophon Therapeutics, Inc.Restricted Stock UnitsA Award—
2019-11-15Bellerophon Therapeutics, Inc.F Tax Payment−$9,225.56
2019-09-26Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2019-01-02Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2018-11-20Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2018-09-25Bellerophon Therapeutics, Inc.A Award—
2018-06-12Bellerophon Therapeutics, Inc.F Tax Payment−$17.7K
2018-01-12Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2018-01-12Bellerophon Therapeutics, Inc.A Award—
2017-03-16Bellerophon Therapeutics, Inc.A Award—
2016-12-07Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2016-09-12Bellerophon Therapeutics, Inc.F Tax Payment−$18.4K
2016-01-19Bellerophon Therapeutics, Inc.A Award—

Recent filings

15

Companies

1

Address

C/O BELLEROPHON THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 301

HAMPTON, NJ, 08827